OrfoNeuro ApS: Financial statements 2021
CVR: 37768901
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -79,332 and a net result of DKK -88,316 compared with DKK -152,909 the year before. Equity in the 2021 report amounted to DKK -504,366.
- Gross Profit
- DKK -79,332
- Profit/Loss
- DKK -88,316
- Equity
- DKK -504,366
- Total Assets
- DKK 46,116
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -79K | -88K | -504K | 0 |
| 2020 | - | -155K | -153K | -416K | 0 |
| 2019 | - | -146K | -140K | -263K | 0 |
| 2018 | - | -204K | -166K | -123K | 0 |
| 2017 | - | -7K | -7K | 43K | 0 |
Official annual report
Find more companies like OrfoNeuro ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
OrfoNeuro ApS has published its annual report for 2020. Gross profit came to DKK -155,041, and the net result was DKK -152,909.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.